(Press-News.org) Common extra heartbeats known as premature ventricular contractions (PVCs) may be a modifiable risk factor for congestive heart failure (CHF) and death, according to researchers at UC San Francisco.
The study, which is in the July 14 issue of the Journal of the American College of Cardiology (JACC), is based on more than a decade of research of 1,139 participants from the national Cardiovascular Health Study.
PVCs are extra, abnormal heartbeats that occur in the ventricles. They disrupt the heart's regular rhythm but usually are no reason for concern or require treatment.
"We cannot exclude the possibility that PVCs are an 'epiphenomenon' or some marker of future heart failure," said senior author Gregory Marcus, MD, MAS, director of clinical research in the UCSF Division of Cardiology. "However, as everyone in our study had no previous history of heart failure and had a normal left ventricle by an ultrasound of the heart, our data would appear to be quite convincing that PVCs represent an important predictor of the disease, causal or not. If indeed there is a causal relationship, this could represent a new approach to preventing heart failure from occurring in the first place."
Earlier studies of patients presenting for catheter ablation suggest that PVCs are a modifiable risk factor for CHF. However, the relationship of PVC frequency, CHF incidents and mortality in the general population is unknown.
Congestive heart failure occurs when the heart does not pump enough blood to meet the body's demands, resulting in reduced blood flow. CHF currently affects more than five million Americans, according to study background, and its prevalence is expected to increase by 25 percent in the next 15 years. Risk factors include obesity, diabetes and hypertension, but up 50 percent of cases have no known cause.
Catheter ablation is a minimally invasive procedure whereby thin, flexible wires called catheters are inserted into a vein and threaded into the heart. The tip of the catheter either delivers heat or extreme cold to destroy tissue responsible for the initiation and/or perpetuation of the abnormal heart rhythm.
In this study, Marcus and his colleagues examined Cardiovascular Health Study participants randomly assigned to 24-hour ambulatory electrocardiography monitoring with a normal left ventricular ejection fraction (LVEF) and no CHF history. Participants were followed for new onset congestive heart failure and death.
The Cardiovascular Health Study is a community-based cohort study sponsored by the National Heart, Lung, and Blood Institute. Nearly 6,000 people age 65 or older were recruited from 1989-1993 and underwent background testing. They then were followed with annual clinical visits and semiannual phone calls for 10 years, followed by just phone calls every six months thereafter.
Among the 1,139 study participants examined for the JACC study, a higher frequency of premature ventricular contractions was associated with LVEF decline, increased CHF incidents and greater mortality.
Because PVCs can be prevented through medical or ablation therapy, this study indicates they may be a modifiable risk factor for congestive heart failure and death.
"Future studies will need to delve into identifying the exact types of patients, and likely the particular types of PVCs, most strongly associated with subsequent heart failure," Marcus said. "Once that occurs, randomized trials among those higher-risk patients to catheter ablation of PVCs, for example, may be warranted."
INFORMATION:
Other contributors to the JACC study were lead author Jonathan Dukes, MD, cardiac electrophysiology fellow, and Eric Vittinghoff, PhD, MPH, professor of epidemiology and biostatistics, from UCSF; Thomas Dewland, MD, of Oregon Health and Science University; Mala Mandyam, MD, of Stanford University School of Medicine; Susan Heckbert, MD, PhD, David Siscovick, MD, MPH, Bruce Psaty, MD, PhD, and Nona Sotoodehnia, MD, of the University of Washington; Phyllis Stein, PhD, of Washington University School of Medicine; John Gottdiener, MD, of the University of Maryland Medical Center.
Funding was provided by the American Heart Association, Joseph Drown Foundation, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke, National Institute on Aging.
UCSF is the nation's leading university exclusively focused on health. Now celebrating the 150th anniversary of its founding as a medical college, UCSF is dedicated to transforming health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with world-renowned programs in the biological sciences, a preeminent biomedical research enterprise and top-tier hospitals, UCSF Medical Center and UCSF Benioff Children's Hospitals. Please visit http://www.ucsf.edu.
(Philadelphia, PA) - Lupus, multiple sclerosis, and type-1 diabetes are among more than a score of diseases in which the immune system attacks the body it was designed to defend. But just why the immune system begins its misdirected assault has remained a mystery.
Now, researchers at Temple University School of Medicine (TUSM) have shown that bacterial communities known as biofilm play a role in the development of the autoimmune disease systemic lupus erythematosus -- a discovery that may provide important clues about several autoimmune ailments.
A team led by TUSM ...
Adolescents who saw advertising for medical marijuana were more likely to either report using marijuana or say they planned to use the substance in the future, according to a new RAND Corporation study.
Studying more than 8,000 Southern California middle school students, researchers found that youth who reported seeing any ads for medical marijuana were twice as likely as peers who reported never seeing an ad to have used marijuana or report higher intentions to use the drug in the future. The study was published online by the journal Psychology of Addictive Behaviors.
Researchers ...
Converting large tracts of the Midwest's marginal farming land to perennial biofuel crops carries with it some key unknowns, including how it could affect the balance of water between rainfall, evaporation and movement of soil water to groundwater.
In humid climates such as the U.S. Midwest, evaporation returns more than half of the annual precipitation to the atmosphere, with the remainder available to recharge groundwater and maintain stream flow and lake levels.
A recent study from the Great Lakes Bioenergy Research Center and published in Environmental Research ...
Worcester, Mass. - A study by a multidisciplinary research team, co-directed by Worcester Polytechnic Institute (WPI), offers new insights into how virulent fungi adapt through genetic modifications to fight back against the effects of medication designed to block their spread, and how that battle leaves them temporarily weakened. These insights may provide clues to new ways to treat notoriously difficult-to-cure fungal infections like thrush and vaginitis.
The team studied patients infected with the fungus Candida albicans (C. albicans), which causes common yeast infections ...
WASHINGTON (July 6, 2015) -- The investigation of a simple protein has uncovered its uniquely complicated role in the spread of the childhood cancer, osteosarcoma. It turns out the protein, called ezrin, acts like an air traffic controller, coordinating multiple functions within a cancer cell and allowing it to endure stress conditions encountered during metastasis.
It's been known that ezrin is a key regulator of osteosarcoma's spread to the lungs, but its mechanism was not known. Osteosarcoma is a tumor of bone that afflicts children, adolescents and young adults. In ...
Mohamed Boutjdir, PhD, professor of medicine, cell biology, and physiology and pharmacology at SUNY Downstate Medical Center, has led a study with international collaborators identifying the mechanism by which patients with various autoimmune and connective tissue disorders may be at risk for life-threatening cardiac events if they take certain anti-histamine or anti-depressant medications. Dr. Boutjdir is also director of the Cardiac Research Program at VA New York Harbor Healthcare System.
The researchers published their findings in the online edition of the American ...
Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal a new pathway that scientists could use to develop more effective treatments and therapies for the chronic lung disorder.
More than 1 in 12 Americans are affected by asthma, a disorder characterized by an overactive immune response to normally harmless substances such as pollen or mold. Scientists had previously discovered that an overabundance of ...
Providers of mental-health services still rely on intervention techniques such as physical restraint and confinement to control some psychiatric hospital patients, a practice which can cause harm to both patients and care facilities, according to a new study from the University of Waterloo.
The study, which appears in a special mental health issue of Healthcare Management Forum, found that almost one in four psychiatric patients in Ontario hospitals are restrained using control interventions, such as chairs that prevent rising, wrist restraints, seclusion rooms or acute ...
Older patients with traumatic spinal cord injury are less likely than younger patients to receive surgical treatment and experience a significant lag between injury and surgery, according to new research in CMAJ (Canadian Medical Association Journal)
The number of people with traumatic spinal cord injury over age 70 is increasing, and it is projected that people in this age group will eventually make up the majority of those with new spinal cord injuries. Currently, most spinal cord injuries occur in people aged 16 to 30 years.
To determine whether patients over age ...
Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price. Now a research team led by the Massachusetts General Hospital (MGH) physician who pioneered the use of inhaled nitric oxide has developed a lightweight, portable system that produces NO from the air by means of an electrical spark. The investigators describe their invention in ...
